{"id":67389,"date":"2026-06-05T13:01:05","date_gmt":"2026-06-05T05:01:05","guid":{"rendered":"https:\/\/flcube.com\/?p=67389"},"modified":"2026-06-05T13:01:06","modified_gmt":"2026-06-05T05:01:06","slug":"ge-healthcare-secures-fda-510k-clearance-for-mim-contour-protegeai-2-0-ai-auto-contouring-platform-with-predetermined-change-control-plan","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=67389","title":{"rendered":"GE HealthCare Secures FDA 510(k) Clearance for MIM Contour Prot\u00e9g\u00e9AI+ 2.0 \u2013 AI Auto-Contouring Platform with Predetermined Change Control Plan"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>GE HealthCare<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/GEHC:NASDAQ\">NASDAQ: GEHC<\/a>) announced it has received <strong>510(k) clearance<\/strong> from the <strong>United States Food and Drug Administration (FDA)<\/strong> for <strong>MIM Contour Prot\u00e9g\u00e9AI+ 2.0<\/strong>, an <strong>AI-enabled auto-contouring software<\/strong> designed to assist radiation oncology care teams with treatment planning.<\/p>\n\n\n\n<h2 id=\"h-regulatory-milestone\" class=\"wp-block-heading\">Regulatory Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Agency<\/strong><\/td><td>FDA (United States)<\/td><\/tr><tr><td><strong>Clearance Type<\/strong><\/td><td>510(k) clearance with Predetermined Change Control Plan (PCCP)<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>MIM Contour Prot\u00e9g\u00e9AI+ 2.0 (AI-enabled auto-contouring software)<\/td><\/tr><tr><td><strong>Indication<\/strong><\/td><td>Treatment planning assistance for radiation oncology care teams<\/td><\/tr><tr><td><strong>Clearance Date<\/strong><\/td><td>4 Jun 2026<\/td><\/tr><tr><td><strong>Key Innovation<\/strong><\/td><td>First radiation oncology AI software with PCCP framework for future model updates<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-technology-profile-amp-clinical-benefits\" class=\"wp-block-heading\">Technology Profile &amp; Clinical Benefits<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Platform:<\/strong> AI-enabled auto-contouring software for radiation therapy treatment planning<\/li>\n\n\n\n<li><strong>Primary Function:<\/strong> Automates anatomical structure outlining on medical images, reducing manual contouring time<\/li>\n\n\n\n<li><strong>Clinical Impact:<\/strong> Enables clinicians to reduce treatment planning time and focus on delivering more timely and personalized patient care<\/li>\n\n\n\n<li><strong>Regulatory Innovation:<\/strong> Includes <strong>Predetermined Change Control Plan (PCCP)<\/strong> that establishes a framework for introducing future model updates without requiring additional clearances<\/li>\n\n\n\n<li><strong>Future Expansion:<\/strong> PCCP will enable expansion of models across additional anatomical regions and imaging modalities<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-strategic-outlook\" class=\"wp-block-heading\">Market Impact &amp; Strategic Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Radiation Oncology AI Market:<\/strong> Growing sector projected to reach $1.2 billion by 2028, with increasing demand for workflow optimization tools<\/li>\n\n\n\n<li><strong>Competitive Advantage:<\/strong> The PCCP framework positions GE HealthCare to rapidly iterate and enhance its AI models, maintaining technological leadership in a fast-evolving field<\/li>\n\n\n\n<li><strong>Clinical Workflow Integration:<\/strong> Reduces administrative burden on radiation oncologists, addressing critical staffing challenges in cancer care delivery<\/li>\n\n\n\n<li><strong>Revenue Potential:<\/strong> Strengthens GE HealthCare&#8217;s position in the precision medicine and oncology informatics segments, complementing existing radiation therapy portfolio<\/li>\n\n\n\n<li><strong>Implementation Strategy:<\/strong> Seamless integration with existing treatment planning systems to minimize disruption to clinical workflows<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding regulatory approvals, product capabilities, and market expectations for MIM Contour Prot\u00e9g\u00e9AI+ 2.0. Actual results may differ due to risks including implementation timelines, market adoption, and competitive dynamics.<a href=\"https:\/\/flcube.com\/\">Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GE HealthCare (NASDAQ: GEHC) announced it has received 510(k) clearance from the United States Food&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[431,1209],"class_list":["post-67389","post","type-post","status-publish","format-standard","hentry","category-company","category-medical-device","tag-ge-healthcare","tag-nasdaq-gehc"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>GE HealthCare Secures FDA 510(k) Clearance for MIM Contour Prot\u00e9g\u00e9AI+ 2.0 \u2013 AI Auto-Contouring Platform with Predetermined Change Control Plan - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"GE HealthCare (NASDAQ: GEHC) announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour Prot\u00e9g\u00e9AI+ 2.0, an AI-enabled auto-contouring software designed to assist radiation oncology care teams with treatment planning.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=67389\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GE HealthCare Secures FDA 510(k) Clearance for MIM Contour Prot\u00e9g\u00e9AI+ 2.0 \u2013 AI Auto-Contouring Platform with Predetermined Change Control Plan\" \/>\n<meta property=\"og:description\" content=\"GE HealthCare (NASDAQ: GEHC) announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour Prot\u00e9g\u00e9AI+ 2.0, an AI-enabled auto-contouring software designed to assist radiation oncology care teams with treatment planning.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=67389\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-05T05:01:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-05T05:01:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67389#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67389\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"GE HealthCare Secures FDA 510(k) Clearance for MIM Contour Prot\u00e9g\u00e9AI+ 2.0 \u2013 AI Auto-Contouring Platform with Predetermined Change Control Plan\",\"datePublished\":\"2026-06-05T05:01:05+00:00\",\"dateModified\":\"2026-06-05T05:01:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67389\"},\"wordCount\":334,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"GE Healthcare\",\"NASDAQ: GEHC\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67389#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67389\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=67389\",\"name\":\"GE HealthCare Secures FDA 510(k) Clearance for MIM Contour Prot\u00e9g\u00e9AI+ 2.0 \u2013 AI Auto-Contouring Platform with Predetermined Change Control Plan - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-06-05T05:01:05+00:00\",\"dateModified\":\"2026-06-05T05:01:06+00:00\",\"description\":\"GE HealthCare (NASDAQ: GEHC) announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour Prot\u00e9g\u00e9AI+ 2.0, an AI-enabled auto-contouring software designed to assist radiation oncology care teams with treatment planning.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67389#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67389\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67389#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GE HealthCare Secures FDA 510(k) Clearance for MIM Contour Prot\u00e9g\u00e9AI+ 2.0 \u2013 AI Auto-Contouring Platform with Predetermined Change Control Plan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GE HealthCare Secures FDA 510(k) Clearance for MIM Contour Prot\u00e9g\u00e9AI+ 2.0 \u2013 AI Auto-Contouring Platform with Predetermined Change Control Plan - Insight, China&#039;s Pharmaceutical Industry","description":"GE HealthCare (NASDAQ: GEHC) announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour Prot\u00e9g\u00e9AI+ 2.0, an AI-enabled auto-contouring software designed to assist radiation oncology care teams with treatment planning.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=67389","og_locale":"en_US","og_type":"article","og_title":"GE HealthCare Secures FDA 510(k) Clearance for MIM Contour Prot\u00e9g\u00e9AI+ 2.0 \u2013 AI Auto-Contouring Platform with Predetermined Change Control Plan","og_description":"GE HealthCare (NASDAQ: GEHC) announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour Prot\u00e9g\u00e9AI+ 2.0, an AI-enabled auto-contouring software designed to assist radiation oncology care teams with treatment planning.","og_url":"https:\/\/flcube.com\/?p=67389","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-05T05:01:05+00:00","article_modified_time":"2026-06-05T05:01:06+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=67389#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=67389"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"GE HealthCare Secures FDA 510(k) Clearance for MIM Contour Prot\u00e9g\u00e9AI+ 2.0 \u2013 AI Auto-Contouring Platform with Predetermined Change Control Plan","datePublished":"2026-06-05T05:01:05+00:00","dateModified":"2026-06-05T05:01:06+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=67389"},"wordCount":334,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["GE Healthcare","NASDAQ: GEHC"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=67389#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=67389","url":"https:\/\/flcube.com\/?p=67389","name":"GE HealthCare Secures FDA 510(k) Clearance for MIM Contour Prot\u00e9g\u00e9AI+ 2.0 \u2013 AI Auto-Contouring Platform with Predetermined Change Control Plan - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-06-05T05:01:05+00:00","dateModified":"2026-06-05T05:01:06+00:00","description":"GE HealthCare (NASDAQ: GEHC) announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour Prot\u00e9g\u00e9AI+ 2.0, an AI-enabled auto-contouring software designed to assist radiation oncology care teams with treatment planning.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=67389#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=67389"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=67389#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"GE HealthCare Secures FDA 510(k) Clearance for MIM Contour Prot\u00e9g\u00e9AI+ 2.0 \u2013 AI Auto-Contouring Platform with Predetermined Change Control Plan"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=67389"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67389\/revisions"}],"predecessor-version":[{"id":67390,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67389\/revisions\/67390"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=67389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=67389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=67389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}